Table 1 Basic information of the included patients undergoing MHD according to the HAMD scores.
Variable | All patients (n = 286) | NDP group (n = 183) | DP group (n = 103) | t/z/χ2 | p-value |
|---|---|---|---|---|---|
Age (y) | 57.64 ± 14.44 | 56.83 ± 14.29 | 59.09 ± 14.65 | −1.27 | 0.205a |
Male (%) | 122 (43) | 76 (42) | 46 (45) | 0.26 | 0.607b |
BMI (Kg/m2) | 22.47 ± 3.35 | 22.59 ± 3.47 | 22.25 ± 3.12 | 0.84 | 0.400a |
Smoke (%) | 127 (44) | 79 (43) | 48 (47) | 0.32 | 0.575b |
Drink (%) | 102 (36) | 63 (34) | 39 (38) | 0.34 | 0.560b |
Time on dialysis (months) | 64.55 ± 45.90 | 66.3 ± 46.32 | 61.9 ± 45.24 | 0.73 | 0.466c |
With diabetes mellitus (%) | 83 (29) | 47 (26) | 36 (35) | 2.75 | 0.097b |
With cardio-cerebrovascular disease (%) | 129 (45) | 68 (37) | 61 (59) | 12.96 | 0.000* |
SBP (mmHg) | 139.82 ± 15.25 | 139.45 ± 15.14 | 140.50 ± 15.52 | −0.56 | 0.576a |
DBP (mmHg) | 75.30 ± 10.32 | 76.22 ± 10.62 | 73.65 ± 9.61 | 2.04 | 0.042a* |
Antiplatelets user (%) | 149 (52) | 90 (49) | 59 (57) | 1.73 | 0.188b |